Digest Network Come funziona
Network
/
Società
Fu
Non verificato

Fujirebio

Di cosa scriviamo

Attrezzature medico-sanitarieBiotecnologiaIndustriaSaluteSanità

14 comunicati stampa

Guarda tutti i comunicati
05/02/2026
Mercato del lavoro
Industria
Biotecnologia
Farmaceutica
Attrezzature medico-sanitarie
Sanità
Salute
Psichiatria
Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing
Fonte
Fujirebio
Emittente
Business Wire
1.00
0
28/01/2026
Sanità
Farmaceutica
Oncologia
Psichiatria
Attrezzature medico-sanitarie
HIV, AIDS e malattie autoimmuni
Biotecnologia
Medicina - Varie
Scienza
Salute
Industria
Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse® G pTau 217 CSF Assay for Research Use Only
Fonte
Fujirebio
Emittente
Business Wire
1.00
0
14/01/2026
Biotecnologia
Sanità
Salute
Farmaceutica
Mercato del lavoro
Notice Concerning Change of Representative Executive Officer
Fonte
Fujirebio
Emittente
Business Wire
1.00
0
23/06/2025
Scienza
Finanza
Associazioni/Professionisti
Biotecnologia
Salute
Mercato azionario
Industria
Fujirebio Acquires Plasma Services Group and Strengthens Its Position as Provider of Critical and High Quality Biological Raw Materials to the IVD and Life Science Industries
Fonte
Fujirebio
Emittente
Business Wire
1.00
0
05/06/2025
Mercato del lavoro
Industria
Salute
HIV, AIDS e malattie autoimmuni
Scienza
Farmaceutica
Biotecnologia
Fujirebio Announces Strategic Collaboration with Stanford Medicine to Advance Infectious Disease Research
Fonte
Fujirebio
Emittente
Business Wire
1.00
0
04/06/2025
Industria
Psichiatria
Salute
Attrezzature medico-sanitarie
Biotecnologia
Sanità
Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse® G sTREM2 Assay for Research Use Only
Fonte
Fujirebio
Emittente
Business Wire
1.00
0
17/05/2025
Industria
Biotecnologia
Salute
Attrezzature medico-sanitarie
Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-vitro Diagnostic Test as an Aid to Identify Patients With Amyloid Pathology Associated With Alzheimer’s Disease
Fonte
Fujirebio
Emittente
Business Wire
1.00
0
23/04/2025
Multimedialità
Industria
Salute
HIV, AIDS e malattie autoimmuni
Scienza
Farmaceutica
Biotecnologia
Grant Award from GHIT Fund for Development of an Ultrasensitive Urine Test for Tuberculosis
Fonte
Fujirebio
Emittente
Business Wire
1.00
0
18/03/2025
Industria
Sanità
Attrezzature medico-sanitarie
HIV, AIDS e malattie autoimmuni
Salute
Fujirebio Europe Launches the INNO-LiPA® HCV 2.0 Genotyping Assay, an Efficient Aid to Personalized HCV Therapy
Fonte
Fujirebio
Emittente
Business Wire
1.00
0
23/12/2024
Biotecnologia
Industria
Sanità
Salute
Oncologia
Scienza
Mercato del lavoro
Fujirebio and Eisai Enter into Memorandum of Understanding for Joint Research and Social Implementation of Blood-based Biomarkers in the Field of Neurodegenerative Diseases
Fonte
Fujirebio
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0